(NASDAQ: CLGN) Collplant Biotechnologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.74%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.81%.
Collplant Biotechnologies's earnings in 2025 is -$13,866,000.On average, 1 Wall Street analyst forecast CLGN's earnings for 2025 to be -$6,414,527, with the lowest CLGN earnings forecast at -$6,414,527, and the highest CLGN earnings forecast at -$6,414,527. On average, 1 Wall Street analyst forecast CLGN's earnings for 2028 to be $5,841,801, with the lowest CLGN earnings forecast at $5,841,801, and the highest CLGN earnings forecast at $5,841,801.
In 2029, CLGN is forecast to generate $13,516,324 in earnings, with the lowest earnings forecast at $13,516,324 and the highest earnings forecast at $13,516,324.